In February February 2024, The Cigna Group entered into ASR agreements to repurchase a total of $3.2 billion of common stock, buying about 9.3 million shares. Including the ASR agreements, the company said it repurchased 14.7 million shares for about $5.0 billion over the 9 months ended September 2024.

1. 01

   In February February 2024, The Cigna Group entered into ASR agreements to repurchase a total of $3.2 billion of common stock, buying about 9.3 million shares. Including the ASR agreements, the company said it repurchased 14.7 million shares for about $5.0 billion over the 9 months ended September 2024.

2. 02

   The company said it repurchased 2.2 million shares for about $715 million from October 1, 2024 through October 30, and that share repurchase authority remained at $5.6 billion as of October 30, 2024.

3. 03

   The company said it had $6.5 billion of undrawn committed capacity under its revolving credit agreements, $4.9 billion of remaining capacity under its commercial paper program and $6.0 billion in cash and short-term investments as of September 30, 2024.

4. 04

   The company said it entered into an agreement in January 2024 to sell its Medicare Advantage and other businesses to HCSC. It expects a transaction value of about $3.7 billion upon closing in Q1 2025, and plans to allocate the majority of the proceeds to share repurchases.

Key figures

Quarter ended September 30, 2024

Revenue

$63.7B

Operating income

$2.6B

Net income

$825M

EPS

$2.63

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.